Engineering of Erythrocytes as Drug Carriers for Therapeutic Applications
Advanced Biology · 2025-05 · 9 (5)
DOI: 10.1002/adbi.202400242 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Biology, online erschienen am 22.07.2024. Verfasst von Baoshuo Jia und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Key Laboratory for Bio-Nanotechnology and M…. Hauptthemen laut MEDLINE: Erythrocytes, Drug Carriers, Drug Delivery Systems. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Natural Science Foundation in Hunan Province.
Abstract (Originalsprache)
Erythrocytes, also known as red blood cells (RBCs), have garnered considerable attention as potential carriers for drug delivery, owing to their inherent properties such as biocompatibility, biodegradability, and prolonged circulation half‐life. This paper presents a comprehensive overview of the role of erythrocytes in drug delivery, elucidating recent advancements in delivering a diverse array of therapeutic agents, including small molecules, nucleic acids, antibodies, protein enzymes, and nanoparticles. Two primary strategies for encapsulating drugs within erythrocytes are systematically discussed: internal loading and surface loading. Each strategy offers distinct advantages in terms of drug stability and release kinetics. Notably, the utilization of erythrocyte membrane camouflaged nanocarriers holds promise for enhancing the biocompatibility of conventional nanoparticles and facilitating targeted drug delivery. Furthermore, the broad spectrum of biomedical applications of erythrocyte‐based drug delivery systems are examined, ranging from cancer treatment to diabetes management, thrombosis prevention, and immunotherapy. This review provides a comprehensive evaluation of current technologies in erythrocyte‐loaded drug delivery, highlighting the strengths, weaknesses, and future directions for advancing therapeutic interventions in various disease contexts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Key Laboratory for Bio-Nanotechnology and Molecular Engineering of Hunan Province, Hunan University, Changsha, 41…
ORCID-Profile: Jianbo Liu
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Natural Science Foundation in Hunan Province
Zitieren
APA
Jia, B., Shi, Y., Yan, Y., Shi, H., Zheng, J., & Liu, J. (2025). Engineering of Erythrocytes as Drug Carriers for Therapeutic Applications. Advanced Biology, 9(5). https://doi.org/10.1002/adbi.202400242
Vancouver
Jia B, Shi Y, Yan Y, Shi H, Zheng J, Liu J. Engineering of Erythrocytes as Drug Carriers for Therapeutic Applications. Advanced Biology. 2025;9(5). doi:10.1002/adbi.202400242
BibTeX
@article{Jia2025,
author = {Jia, Baoshuo and Shi, Yujie and Yan, Yuling and Shi, Hui and Zheng, Jing and Liu, Jianbo},
title = {Engineering of Erythrocytes as Drug Carriers for Therapeutic Applications},
journal = {Advanced Biology},
year = {2025},
volume = {9},
number = {5},
doi = {10.1002/adbi.202400242}
}
EUVIMED